830346-47-9 = 830346-48-0 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; < 1 H,Rt; 2 H,Rt 标题:Discovery Of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-Methoxyphenyl)-3-(2-Fluoro-6-[trifluoromethyl]Benzyl)-4-Methyl-2,6-Dioxo-3,6-Dihydro-2H-Pyrimidin-1-Yl]-1-Phenylethylamino}Butyrate (Elagolix),A Potent And Orally Available Nonpeptide Antagonist Of The Human Gonadotropin-Releasing Hormone Receptor 作者:Chen,Chen; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2008 卷标:51(23) 页码:7478-7485]
830346-47-9 = 830346-48-0 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 20 Min,Rt; 2 H,Rt 标题:Elagolix Sodium Salt And Its Synthetic Intermediates: A Spectroscopic,Crystallographic,And Conformational Study 作者:Ciceri,Samuele; Et Al 参考文献:Molecules 日期:2023 卷标:28(9)]
830346-46-8 + 1694-31-1 = 830346-48-0 反应条件:1.1 Solvents: Toluene; Reflux1.2 Reagents: P-Toluenesulfonic Acid; Reflux2.1 Reagents: Bromine Solvents: Acetic Acid; 20 Min,Rt; 2 H,Rt 标题:Elagolix Sodium Salt And Its Synthetic Intermediates: A Spectroscopic,Crystallographic,And Conformational Study 作者:Ciceri,Samuele; Et Al 参考文献:Molecules 日期:2023 卷标:28(9)]
830346-46-8 = 830346-48-0 反应条件:1.1 Reagents: Chlorotrimethylsilane,Sodium Iodide Solvents: Acetonitrile; 0 °C; 0 °C -> Rt; 20 H,Rt2.1 Reagents: Bromine Solvents: Acetic Acid; < 1 H,Rt; 2 H,Rt 标题:Discovery Of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-Methoxyphenyl)-3-(2-Fluoro-6-[trifluoromethyl]Benzyl)-4-Methyl-2,6-Dioxo-3,6-Dihydro-2H-Pyrimidin-1-Yl]-1-Phenylethylamino}Butyrate (Elagolix),A Potent And Orally Available Nonpeptide Antagonist Of The Human Gonadotropin-Releasing Hormone Receptor 作者:Chen,Chen; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2008 卷标:51(23) 页码:7478-7485]
239087-06-0 + 57-13-6 = 830346-48-0 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Water; Reflux2.1 Solvents: Toluene; Reflux2.2 Reagents: P-Toluenesulfonic Acid; Reflux3.1 Reagents: Bromine Solvents: Acetic Acid; 20 Min,Rt; 2 H,Rt 标题:Elagolix Sodium Salt And Its Synthetic Intermediates: A Spectroscopic,Crystallographic,And Conformational Study 作者:Ciceri,Samuele; Et Al 参考文献:Molecules 日期:2023 卷标:28(9)]
133116-83-3 = 830346-48-0 反应条件:1.1 Reagents: (T-4)-Trihydro(Tetrahydrofuran)Boron Solvents: Tetrahydrofuran; 60 °C; Overnight,Reflux; Reflux -> Rt2.1 Reagents: Hydrochloric Acid Solvents: Water; 6 H,Reflux; Reflux -> 0 °C3.1 Reagents: Chlorotrimethylsilane,Sodium Iodide Solvents: Acetonitrile; 0 °C; 0 °C -> Rt; 20 H,Rt4.1 Reagents: Bromine Solvents: Acetic Acid; < 1 H,Rt; 2 H,Rt 标题:Discovery Of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-Methoxyphenyl)-3-(2-Fluoro-6-[trifluoromethyl]Benzyl)-4-Methyl-2,6-Dioxo-3,6-Dihydro-2H-Pyrimidin-1-Yl]-1-Phenylethylamino}Butyrate (Elagolix),A Potent And Orally Available Nonpeptide Antagonist Of The Human Gonadotropin-Releasing Hormone Receptor 作者:Chen,Chen; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2008 卷标:51(23) 页码:7478-7485
2-氟-6-(三氟甲基)苯腈置于盐酸,硼烷四氢呋喃络合物,水,溴,溶剂黄146,Sodium Iodide体系中,用 四氢呋喃,乙腈 作为反应溶剂,化学反应 28.0H,反应生成 5-溴-1-(2-氟-6-(三氟甲基)苄基)-4-羟基-6-甲基嘧啶-2(1H)-酮 参考文献: Uracil-Type Gonadotropin-Releasing Hormone Receptor Antagonists And Methods Related Thereto[fr] Antagonistes De Type Uracil Gonadolibérine Et Les Méthodes Afférentes 标题: Uracil-Type Gonadotropin-Releasing Hormone Receptor Antagonists And Methods Related Thereto[fr] Antagonistes De Type Uracil Gonadolibérine Et Les Méthodes Afférentes 摘要:具有作为gnrh受体拮抗剂的效用,并用于治疗男性和女性的各种与性激素相关疾病的化合物.这些化合物具有以下结构(i):(i)其中r1A,R1B,R1C,R2A,R2B,R3,R4,R5,R6,R7,N和x如本文所定义,包括立体异构体,前药和其药用可接受盐.还公开了含有结构(i)化合物的组合物,与药用可接受载体结合,以及与使用该组合物拮抗需要该物质的受试者中的促性腺激素释放激素相关的方法.
专利号:US-11858901-B2 优先权日:2019-10-30 标 题:3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6 trifluoromethyl benzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione or a salt thereof, process for its preparation, and its use in the synthesis of elagolix 发明人:BALLETTE ROBERTO; JIMÉNEZ ALONSO OSCAR; GARCÃ?A GARCÃ?A ELENA; DOBARRO RODRÃ?GUEZ ALICIA 权利人:MOEHS IBERICA SL 摘要:A new intermediate is useful in the synthesis of elagolix. A process for obtaining the intermediate includes reacting a precursor with iodine monochloride in the presence of an organic solvent. A process for preparing elagolix makes use of the intermediate. The intermediate can be 3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6-trifluoromethylbenzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione or a salt thereof, such as a hydrochloride.
专利号:US-11840519-B2 优先权日:2019-09-03 标 题 :Process for the synthesis of the sodium salt of 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl]-3,6-dihydro-4-methyl-2.6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-butanoic acid (elagolix sodium salt) and intermediates of said process 发明人:LENNA ROBERTO; FASANA ANDREA; ORTIZ JERRY 权利人:IND CHIMICA SRL 摘要:The present invention to a process for the preparation of the sodium salt of 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-amino]-butanoic acid, compound also known as Elagolix sodium salt, having the formula (I) reported below:
专利号:US-2022281829-A1 优先权日:2019-09-03 标题 :Process for the synthesis of the sodium salt of 4-[[(1r)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl]-3,6-dihydro-4-methyl-2,6- dioxo-1(2h)-pyrimidinyl]-1- phenylethyl]amino]-butanoic acid (elagolix sodium salt) and intermediates of said process
专利号:WO-2021044230-A1 优先权日:2019-09-03 标题:Process for the synthesis of the sodium salt of 4-[[(lr)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-l(2h)-pyrimidinyl]-l- phenylethyl]amino]-butanoic acid (elagolix sodium salt) and intermediates of said process
专利号:CA-3149179-A1 优先权日:2019-09-03 标题:Process for the synthesis of the sodium salt of 4-[[(1r)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2h)-pyrimidinyl]-1-phenylethyl]amino]-butanoic acid (elagolix sodium salt) and intermediates of said process
专利号:ES-2915123-B2 优先权日:2019-09-03 标 题:Process for the synthesis of the sodium salt of 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl acid ]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-butanoic acid (Elagolix sodium salt) and intermediate products of said process